Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTJMF9P)

DTT Name	ITGA4 messenger RNA (ITGA4 mRNA) DTT Info
Gene Name	ITGA4

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

1 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ATL1102	DM3POT6	Multiple sclerosis	8A40	Phase 2	[1]
------------------------------------------------------------------------------------

6 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ISIS 24448	DMLHQ2J	Discovery agent	N.A.	Investigative	[2]
ISIS 24453	DM45WUZ	Discovery agent	N.A.	Investigative	[2]
ISIS 24454	DMDE3J1	Discovery agent	N.A.	Investigative	[2]
ISIS 24475	DMBKZOQ	Discovery agent	N.A.	Investigative	[2]
ISIS 24477	DMCNBIL	Discovery agent	N.A.	Investigative	[2]
MK-0668	DMVBFJP	Discovery agent	N.A.	Investigative	[3]
------------------------------------------------------------------------------------


⏷ Show the Full List of 6 Investigative Drug(s)

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS.Neurology.2014 Nov 11;83(20):1780-8.
2	US patent application no. 6,258,790, Antisense modulation of integrin .alpha.4 expression.
3	Discovery of N-{N-[(3-cyanobenzene) sulfonyl]-4(R)-(3,3-difluoropiperidin-1-yl)-(l)-prolyl}-4-[(3',5'-dichloro-isonicotinoyl) amino]-(l)-phenylalan... Bioorg Med Chem Lett. 2009 Oct 1;19(19):5803-6.